Tugce Canavar Yildirim

About Tugce Canavar Yildirim

Tugce Canavar Yildirim, With an exceptional h-index of 3 and a recent h-index of 3 (since 2020), a distinguished researcher at Bilkent Üniversitesi, specializes in the field of immunology, biochemistry.

His recent articles reflect a diverse array of research interests and contributions to the field:

Immunogenicity and Protective Capacity of CpG ODN Adjuvanted Alum Adsorbed Bivalent Meningococcal Outer Membrane Vesicle Vaccine

The effect of exosomes released from apheresis platelet concentrates under the impact of gamma irradiation and storage time upon platelet aggregation and hemostasis

Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastoris

Hexokinase 1b is a novel target for Non–small-cell lung cancer

Development and preclinical evaluation of virus‐like particle vaccine against COVID‐19 infection

Development and Preclinical Evaluation of Virus Like Particle Vaccine Against COVID-19 Infection (preprint)

Helper T cell responses in SARS-CoV-2 virus like particle vaccinated mice

Virus Like Particle (VLP)-based SARS-CoV-2 vaccine induces a potent immune response in rats

Tugce Canavar Yildirim Information

University

Position

Molecular Biology and Genetics

Citations(all)

66

Citations(since 2020)

66

Cited By

4

hIndex(all)

3

hIndex(since 2020)

3

i10Index(all)

3

i10Index(since 2020)

3

Email

University Profile Page

Google Scholar

Tugce Canavar Yildirim Skills & Research Interests

immunology

biochemistry

Top articles of Tugce Canavar Yildirim

Immunogenicity and Protective Capacity of CpG ODN Adjuvanted Alum Adsorbed Bivalent Meningococcal Outer Membrane Vesicle Vaccine

International immunology

2024/3/27

The effect of exosomes released from apheresis platelet concentrates under the impact of gamma irradiation and storage time upon platelet aggregation and hemostasis

Blood Transfusion

2023/5

Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastoris

Scientific reports

2023/3/30

Development and preclinical evaluation of virus‐like particle vaccine against COVID‐19 infection

Allergy

2022/1

Development and Preclinical Evaluation of Virus Like Particle Vaccine Against COVID-19 Infection (preprint)

2021/7/14

Helper T cell responses in SARS-CoV-2 virus like particle vaccinated mice

European Journal of Immunology

2021

Virus Like Particle (VLP)-based SARS-CoV-2 vaccine induces a potent immune response in rats

European Journal of Immunology

2021

Virus like particle formation by using 4 structural proteins of SARS-Cov-2 and investigation of its effectiveness among wild type and prefusion stabilized spike variants

European Journal of Immunology

2021

Ex vivo Th-1 biasing T cell responses in alum-adsorbed SARS-CoV-2 inactivated virus vaccine adjuvanted with K-type CpG ODN

European Journal of Immunology

2021

Circulating extracellular vesicles of patients with steroid-sensitive nephrotic syndrome have higher RAC1 and induce recapitulation of nephrotic syndrome phenotype in podocytes

American Journal of Physiology-Renal Physiology

2021/11/1

TLR ligand loaded exosome mediated immunotherapy of established mammary Tumor in mice

Immunology Letters

2021/11/1

Tugce Canavar Yildirim
Tugce Canavar Yildirim

H-Index: 1

Ozgur Sahin
Ozgur Sahin

H-Index: 17

Ihsan Gursel
Ihsan Gursel

H-Index: 25

Exosomes co-encapsulating antigen and immunoadjuvants act as an effective therapeutic cancer vaccine

2021/8/1

Tugce Canavar Yildirim
Tugce Canavar Yildirim

H-Index: 1

Fuat Cem Yagci
Fuat Cem Yagci

H-Index: 6

Ihsan Gursel
Ihsan Gursel

H-Index: 25

A suppressive oligodeoxynucleotide expressing TTAGGG motifs modulates cellular energetics through the mTOR signaling pathway

International immunology

2020/1

See List of Professors in Tugce Canavar Yildirim University(Bilkent Üniversitesi)